Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1386886

registered interest
date	10/12/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Quarantine
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether people who have received a covid-19 vaccination outside of the UK are required to self-isolate if they’ve been in contact with someone with covid-19.
tabling member constituency	Brentford and Isleworth
tabling member printed	Ruth Cadbury
uin	90889
answer	answer is ministerial correction date of answer 20/12/2021 answer text <p>Since 9 December, those recognised as fully vaccinated under the United Kingdom’s travel policy have also been treated as fully vaccinated for the purposes of self-isolation. They are exempt from self-isolation if they have been in close contact with a positive COVID-19 case. However, anyone aged five years old and over living in the same household as someone with COVID-19 and who is not legally required to self-isolate is now strongly advised to take a lateral flow test (LFD) test every day for seven days. If a LFD test is positive, they should self-isolate in order to protect other people. The public health advice for people with symptoms of or a positive test result for COVID-19 remains the same.</p> answering member constituency Erewash answering member printed Maggie Throup question first answered 20/12/2021 14:36:12 answering member 4447 label Biography information for Maggie Throup
tabling member	4389 label Biography information for Ruth Cadbury

1386899

registered interest
date	10/12/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Ichthyosis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that people with the skin condition ichthyosis can access the cream Udrate to treat that condition via (a) GP prescription and (b) pharmacies nationwide.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	90870
answer	answer is ministerial correction date of answer 16/12/2021 answer text <p>No assessment has been made. General practitioners and clinician are responsible for working with patients to determine the appropriate course of treatment, with the provision of the most clinically appropriate care being the primary consideration. Clinicians are responsible for making prescribing decisions for their patients, taking into account best prescribing practice and the decision-making of their respective clinical commissioning groups.</p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 90871 question first answered 16/12/2021 17:10:19 answering member 4362 label Biography information for Edward Argar
tabling member	4079 label Biography information for Julian Sturdy

1386900

registered interest
date	10/12/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Ichthyosis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of local variation in access to the cream Udrate for the treatment of the skin condition ichthyosis.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	90871
answer	answer is ministerial correction date of answer 16/12/2021 answer text <p>No assessment has been made. General practitioners and clinician are responsible for working with patients to determine the appropriate course of treatment, with the provision of the most clinically appropriate care being the primary consideration. Clinicians are responsible for making prescribing decisions for their patients, taking into account best prescribing practice and the decision-making of their respective clinical commissioning groups.</p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 90870 question first answered 16/12/2021 17:10:19 answering member 4362 label Biography information for Edward Argar
tabling member	4079 label Biography information for Julian Sturdy

1386902

registered interest
date	10/12/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, which hospital trusts are providing covid-19 vaccinations at antenatal clinics; and from what date each of those clinics began providing those vaccinations.
tabling member constituency	Walthamstow
tabling member printed	Stella Creasy
uin	90872
answer	answer is ministerial correction date of answer 31/12/2021 answer text <p>The information requested is not held centrally. There are also a number of ways pregnant women can receive these vaccinations on a walk-in basis. NHS England is working with vaccination leads to increase the availability of walk-in vaccination clinics for pregnant women within or on the same site as maternity services.</p> answering member constituency Erewash answering member printed Maggie Throup question first answered 31/12/2021 12:26:44 answering member 4447 label Biography information for Maggie Throup previous answer version 39490 answering member constituency Erewash answering member printed Maggie Throup answering member 4447 label Biography information for Maggie Throup
tabling member	4088 label Biography information for Stella Creasy

1386906

registered interest
date	10/12/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Influenza: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that people with (a) invasive pneumococcal disease and (b) other underlying health conditions receive their flu vaccination in addition to their covid-19 booster vaccination.
tabling member constituency	Linlithgow and East Falkirk
tabling member printed	Martyn Day
uin	90920
answer	answer is ministerial correction date of answer 20/12/2021 answer text <p>National guidance on influenza vaccination recommends that if an individual is acutely unwell, immunisation may be postponed until they have fully recovered. Patients unwell with invasive pneumococcal disease would typically have any influenza vaccine that they were due to receive deferred until recovery. Those considered to be in risk groups for invasive pneumococcal disease may also be eligible for a flu vaccine.</p><p>To encourage uptake, NHS England and NHS Improvement have recommissioned the national call and recall service for the 2021/22 season. This service will complement local mechanisms to target groups of eligible individuals, informing them of their eligibility and inviting them to make an appointment for their flu vaccination.</p><p>The ‘Boost Your Immunity This Winter’ campaign launched in October included targeted communications for those with underlying health conditions to raise awareness of the risks of flu and COVID-19 and their eligibility for the vaccinations as the best protection from serious illness.</p> answering member constituency Erewash answering member printed Maggie Throup question first answered 20/12/2021 15:11:14 answering member 4447 label Biography information for Maggie Throup
tabling member	4488 label Biography information for Martyn Day

1386907

registered interest
date	10/12/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Vaccination: Immunosuppression
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to assess immunogenicity for future vaccines to ensure that people who are immunosuppressed are protected against vaccine-preventable diseases.
tabling member constituency	Linlithgow and East Falkirk
tabling member printed	Martyn Day
uin	90921
answer	answer is ministerial correction date of answer 04/01/2022 answer text <p>Immunogenicity for future vaccines cannot be assessed until vaccines are tested in clinical trials. All vaccines must first be assessed for safety by the Medicines and Healthcare products Regulatory Agency. It is the responsibility of vaccine manufacturers to include immunosuppressed individuals and assess immunogenicity in clinical trials.</p> answering member constituency Erewash answering member printed Maggie Throup question first answered 04/01/2022 10:13:44 answering member 4447 label Biography information for Maggie Throup
tabling member	4488 label Biography information for Martyn Day

1386912

registered interest
date	10/12/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Brain: Tumours
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what his timeframe is for the allocation of funding to brain tumour research.
tabling member constituency	Belfast South
tabling member printed	Claire Hanna
uin	90958
answer	answer is ministerial correction date of answer 16/12/2021 answer text <p>In May 2018 the Government announced £40 million over five years for brain tumour research as part of the Tessa Jowell Brain Cancer Mission, through the National Institute for Health Research (NIHR). The NIHR released a public announcement to the research community, making clear our desire to receive brain tumour research funding applications. We are relying on researchers to submit high-quality research proposals.</p><p>As with other Government funders of health research, the NIHR does not allocate funding for specific disease areas. The level of research spend in a particular area is determined by factors including scientific potential and the number and scale of successful funding applications. The NIHR welcomes funding applications for research into any aspect of human health, including brain tumours.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 16/12/2021 17:01:35 answering member 4492 label Biography information for Maria Caulfield
tabling member	4827 label Biography information for Claire Hanna

1386922

registered interest
date	10/12/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Integrated Care Boards: Business Interests
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 1 December 2021 to Question 80412 on Integrated Care Boards: Conflict of Interests, if he will take steps to create a centralised register of interests for the purpose of public accessibility.
tabling member constituency	Norwich South
tabling member printed	Clive Lewis
uin	90922
answer	answer is ministerial correction date of answer 16/12/2021 answer text <p>There are no plans for a centralised register of conflicts of interest.</p><p>Integrated care boards will be required to maintain and publish a register of their members’ interests and to outline arrangements for the management of conflicts or potential conflicts of interest. These will be published for public access.</p> answering member constituency Charnwood answering member printed Edward Argar question first answered 16/12/2021 16:05:54 answering member 4362 label Biography information for Edward Argar
tabling member	4500 label Biography information for Clive Lewis

1386923

registered interest
date	10/12/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the announcement of 8 December 2021 on the PANORAMIC trial, UK's most vulnerable people to receive life-saving covid-19 treatments in the community, if he will make it his policy to allow clinically vulnerable people to register their willingness to participate in the study with their GP, in advance of either displaying symptoms of covid-19, or receiving a positive PCR test result.
tabling member constituency	St Albans
tabling member printed	Daisy Cooper
uin	90948
answer	answer is ministerial correction date of answer 20/12/2021 answer text <p>The PANORAMIC study is open to individuals aged over 50 years old or 18 to 49 years old with an underlying medical condition and a positive polymerase chain reaction (PCR) test for COVID-19. Individuals cannot currently register their interest in taking part in the study in advance of displaying symptoms or receiving a positive PCR test, although they will be contacted upon testing positive. However, upon receipt of a positive test they can register at the study’s website or they will be contacted by the study team or a local healthcare professional to consider enrolling. Individuals who are at greatest risk from COVID-19 will receive a letter by Christmas to alert them they may be eligible for direct access to treatments. When those within this group test positive, they will be contacted and assessed by a clinician from a COVID Medicines Delivery Unit to discuss what treatments could be suitable.</p> answering member constituency Erewash answering member printed Maggie Throup question first answered 20/12/2021 12:18:55 answering member 4447 label Biography information for Maggie Throup previous answer version 39485 answering member constituency Erewash answering member printed Maggie Throup answering member 4447 label Biography information for Maggie Throup
tabling member	4769 label Biography information for Daisy Cooper

1386926

registered interest
date	10/12/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Drugs: Rehabilitation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the implications for his policies of the Substance misuse treatment for adults: statistics 2020 to 2021 published by the Office for Health Improvement and Disparities on 25 November 2021.
tabling member constituency	Easington
tabling member printed	Grahame Morris
uin	90864
answer	answer is ministerial correction date of answer 20/12/2021 answer text <p>We continually assess the latest data, including the ‘Substance misuse treatment for adults: statistics 2020 to 2021’. The data shows the number of adults entering treatment in 2020/21 was broadly similar to the previous year.</p><p>On 6 December, the Government published its new ten-year drug strategy which sets out how we will tackle drug crime and improve treatment. Over the next three years, we will invest £780 million in treatment and recovery. This new funding will allow local authorities to provide high quality treatment for people addicted to harmful substances and reduce deaths from substance abuse, as well as providing housing and employment support.</p> answering member constituency Erewash answering member printed Maggie Throup question first answered 20/12/2021 15:00:28 answering member 4447 label Biography information for Maggie Throup previous answer version 39474 answering member constituency Erewash answering member printed Maggie Throup answering member 4447 label Biography information for Maggie Throup
tabling member	3973 label Biography information for Grahame Morris